Supply assurance: working to ensure there's no shortage of it
In today's global market, we want to give providers confidence that critical supplies and essential medications are accessible when needed in delivering high-quality patient care. It's supply assurance, and it's part of our long-standing core business.
Our wealth of experience, actionable data and predictive planning helps to strengthen supply assurance. Further, our work with stakeholders focuses on improving supply chain risk mitigation as we collaborate to enhance data, increase supply visibility and expand inventory access.
Four themes keep us centered and are the pillars of our supply chain assurance efforts: insights, access, enablement and advocacy. Learn more about our supply assurance strategy.
Supply assurance expert insights and news
Akorn Pharmaceuticals closure: read our conclusions, recommendations and mitigation strategies
2022 in Review: Lessons Learned in Supply Assurance Lead to Increased Collaboration, Ingenuity
Transparency Trumpeted as Key to Supply Resiliency
Building supply assurance: balancing opportunities, recognizing risks
Amid a Strained Healthcare Supply Chain, Stateside Takes Stride
Summit Trumpets Transparency as Key to Supply Resiliency
How we can help improve your access to essential medications and critical supplies
Supply assurance weekly digestWant to continue receiving weekly supply assurance updates? Update your preferences in our Subscription Manager by selecting Supply Assurance Weekly Digest.
Improving care with additional essential product access
Novaplus Enhanced Supply delivers access to additional inventory of essential medications and products. Our awarded suppliers produce additional supply to mitigate supply chain risk.
Connecting industry leaders to end drug shortages
The End Drug Shortage Alliance is a collaboration of select health systems, leaders in supply chain and other industry stakeholders dedicated to solving pharmaceutical supply challenges.